XBiotech Inc.
XBIT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626878
No open-market purchases or sales by XBiotech Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $4.56M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding XBiotech Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 56 | 45 | −11 |
| Shares | 3.36M | 3.06M | −301.8K (−9.0%) |
| Value | $18.9M | $11.1M | −$7.84M (−41.5%) |
New holders (5)
Institutions that held XBiotech Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| RBF Capital, LLC | 23,172 | $84.0K | 0.01% |
| Susquehanna Fundamental Investments, LLC | 21,400 | $77.0K | 0.00% |
| Man Group plc | 17,300 | $63.0K | 0.00% |
| Jane Street Group, LLC | 10,439 | $38.0K | 0.00% |
| Capital Advisors, Ltd. LLC | 209 | $1.00K | 0.00% |
Sold out (16)
Institutions that held XBiotech Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Citadel Advisors LLC | 80,884 | $455.0K |
| Ergoteles LLC | 70,114 | $395.0K |
| Cubist Systematic Strategies, LLC | 27,251 | $153.0K |
| Susquehanna International Group, LLP | 22,799 | $128.0K |
| Jump Financial, LLC | 18,538 | $104.0K |
| PDT Partners, LLC | 16,976 | $96.0K |
| Squarepoint Ops LLC | 11,189 | $63.0K |
| Goldman Sachs Group Inc | 10,102 | $57.0K |
| Group One Trading, L.P. | 4,000 | $23.0K |
| Legal & General Group Plc | 1,257 | $7.00K |
| New York State Common Retirement Fund | 140 | $1.00K |
| Citigroup Inc | 151 | $1.00K |
| Simplex Trading, LLC | 146 | $0 |
| Captrust Financial Advisors | 21 | $0 |
| CWM, LLC | 28 | $0 |
| Lindbrook Capital, LLC | 66 | $0 |